[Webinar] How to better optimize an oncology drug discovery program
Register for this webinar discussing how conventional and innovative integrated technological skills should be incorporated into an oncology program.Read more
Streamline the choice of therapeutic direction for your projects by qualifying the potential of your molecules and your in vitro targets.
T.O.T. qualifies the therapeutic potential of a target or molecule in vitro: cell imaging, new phenotype tests on 3D tissue cultures, molecular characterization of signaling pathways, etc.
Linked to our patient-derived PDX experimental models and the analysis of associated clinical data, T.O.T. Allows you to experimentally reconstruct a patient cohort in order to confirm or adjust a preclinical and clinical development strategy.
Discovering new targets to overcome treatment resistance in Oncology
Nanocyclix®, paving the way for new kinases of therapeutic interest